Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.

Hapakova N, Sestakova Z, Holickova A, Hurbanova L, Miskovska V, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Obertova J, Palacka P, Sycova-Mila Z, Mardiak J, Chovanec M, Mego M.

Clin Genitourin Cancer. 2019 Jun 13. pii: S1558-7673(19)30197-1. doi: 10.1016/j.clgc.2019.06.004. [Epub ahead of print]

PMID:
31281064
2.

Intraoperative tumor lysis syndrome in a giant teratoma: a case report.

Pindak D, Rejlekova K, Tomas M, Aziri R, Rovenska E, Puskacova J, Mego M.

BMC Surg. 2019 Jun 14;19(1):62. doi: 10.1186/s12893-019-0526-4.

3.

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.

De Padova S, Casadei C, Berardi A, Bertelli T, Filograna A, Cursano MC, Menna C, Burgio SL, Altavilla A, Schepisi G, Prati S, Montalti S, Chovanec M, Banna GL, Grassi L, Mego M, De Giorgi U.

Front Endocrinol (Lausanne). 2019 May 28;10:318. doi: 10.3389/fendo.2019.00318. eCollection 2019. Review.

4.

Immune mechanisms and possible immune therapy in testicular germ cell tumours.

Chovanec M, Mardiak J, Mego M.

Andrology. 2019 Jun 6. doi: 10.1111/andr.12656. [Epub ahead of print] Review.

PMID:
31169364
5.

Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.

Mego M, Svetlovska D, Chovanec M, Rečkova M, Rejlekova K, Obertova J, Palacka P, Sycova-Mila Z, De Giorgi U, Mardiak J.

Invest New Drugs. 2019 Aug;37(4):748-754. doi: 10.1007/s10637-019-00805-4. Epub 2019 Jun 1.

PMID:
31152292
6.

Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome.

Rejlekova K, Cursano MC, De Giorgi U, Mego M.

Front Endocrinol (Lausanne). 2019 Apr 12;10:218. doi: 10.3389/fendo.2019.00218. eCollection 2019. Review.

7.

Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.

Mikudova V, Rejlekova K, Gyarfas J, Oravcova I, Chovanec M, Mardiak J, Mego M.

Klin Onkol. 2019 Spring;32(2):139-142. doi: 10.14735/amko2018139.

PMID:
30995855
8.

Clinical Management and Outcome in Extreme Retroperitoneal Growing Teratoma Syndrome of Testicular Origin - Clinical Management and Effect of the Treatment.

Huľová S, Aziri R, Chovanec M, Mardiak J, Mego M, Pinďák D.

Klin Onkol. 2019 Spring;32(2):129-132. doi: 10.14735/amko2019129.

PMID:
30995853
9.

Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.

Mego M, Karaba M, Minarik G, Benca J, Silvia J, Sedlackova T, Manasova D, Kalavska K, Pindak D, Cristofanilli M, Reuben JM, Mardiak J.

Anticancer Res. 2019 Apr;39(4):1829-1837. doi: 10.21873/anticanres.13290.

PMID:
30952723
10.

Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical management.

Casadei C, Schepisi G, Menna C, Chovanec M, Gurioli G, Gallà V, Altavilla A, Marcellini M, Bellia SR, Lolli C, Mego M, Rosti G, De Giorgi U.

Future Oncol. 2019 Apr;15(12):1347-1352. doi: 10.2217/fon-2018-0850. Epub 2019 Mar 18.

PMID:
30880465
11.

A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.

Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I.

Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18.

12.

Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.

Chovanec M, Albany C, Mego M, Montironi R, Cimadamore A, Cheng L.

Front Oncol. 2018 Nov 28;8:571. doi: 10.3389/fonc.2018.00571. eCollection 2018.

13.

Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.

Huľová S, Sycova-Mila Z, Macák D, Janega P, Chovanec M, Mardiak J, Mego M.

Klin Onkol. Fall 2018;31(6):448-452. doi: 10.14735/amko2018448.

PMID:
30545225
14.

Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patient‑derived xenograft models.

Kalavska K, Kucerova L, Schmidtova S, Toro L, Kozovska Z, Plank L, Chovanec M, Palacka P, Pindak D, Macak D, Mardiak J, Mego M.

Oncol Rep. 2018 Dec;40(6):3593-3602. doi: 10.3892/or.2018.6769. Epub 2018 Oct 5.

PMID:
30542732
15.

Clinical utility of plasma miR-371a-3p in germ cell tumors.

Mego M, van Agthoven T, Gronesova P, Chovanec M, Miskovska V, Mardiak J, Looijenga LHJ.

J Cell Mol Med. 2019 Feb;23(2):1128-1136. doi: 10.1111/jcmm.14013. Epub 2018 Dec 7.

16.

βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors.

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, Mego M, Mardiak J.

BMC Cancer. 2018 Nov 3;18(1):1062. doi: 10.1186/s12885-018-4929-x.

17.

Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients.

Kalavska K, Minarik T, Vlkova B, Manasova D, Kubickova M, Jurik A, Mardiak J, Sufliarsky J, Celec P, Mego M.

J Ovarian Res. 2018 Sep 22;11(1):85. doi: 10.1186/s13048-018-0459-z.

18.

Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers.

Kalinkova L, Zmetakova I, Smolkova B, Minarik G, Sedlackova T, Horvathova Kajabova V, Cierna Z, Mego M, Fridrichova I.

BMC Cancer. 2018 Sep 6;18(1):875. doi: 10.1186/s12885-018-4783-x.

19.

Duodenal obstruction due to intramural haematoma as a complication of endoscopic biopsy.

Mego M, Lugo N, Roura J, Saperas E.

Gastroenterol Hepatol. 2019 Jun - Jul;42(6):381-382. doi: 10.1016/j.gastrohep.2018.07.011. Epub 2018 Aug 25. English, Spanish. No abstract available.

PMID:
30153947
20.

Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders.

Huaman JW, Mego M, Manichanh C, Cañellas N, Cañueto D, Segurola H, Jansana M, Malagelada C, Accarino A, Vulevic J, Tzortzis G, Gibson G, Saperas E, Guarner F, Azpiroz F.

Gastroenterology. 2018 Oct;155(4):1004-1007. doi: 10.1053/j.gastro.2018.06.045. Epub 2018 Jun 30.

PMID:
29964041
21.

A unique clinical presentation of de novo acute promyelocytic leukemia as a myeloid sarcoma of the breast.

Oravcova I, Mikuskova E, Leitnerova M, Gyarfas J, Mlcakova A, Szepe P, Plank L, Demitrovicova L, Mikudova V, Cingelova S, Mego M, Drgona L.

Int J Hematol. 2018 Nov;108(5):550-553. doi: 10.1007/s12185-018-2479-2. Epub 2018 Jun 21.

PMID:
29931624
22.

Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Chovanec M, De Giorgi U, Mego M.

Adv Urol. 2018 Mar 13;2018:3718165. doi: 10.1155/2018/3718165. eCollection 2018. Review.

23.

Systemic immune-inflammation index in germ-cell tumours.

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J.

Br J Cancer. 2018 Mar 20;118(6):831-838. doi: 10.1038/bjc.2017.460. Epub 2018 Feb 27.

24.

Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.

Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M.

Oncologist. 2018 May;23(5):617-623. doi: 10.1634/theoncologist.2017-0457. Epub 2018 Jan 19.

25.

Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.

Kalavska K, Conteduca V, De Giorgi U, Mego M.

Curr Cancer Drug Targets. 2018;18(10):967-978. doi: 10.2174/1568009618666180102103959.

PMID:
29295694
26.

Undifferentiated Carcinoma of the Pancreas - a Case Report.

Kašperová B, Jurišová S, Macúch J, Bumberová M, Janega P, Dolinský J, Mego M.

Klin Onkol. 2018 Winter;31(6):453-456. doi: 10.14735/amko2018453.

PMID:
31035768
27.

Down-regulation of traditional oncomiRs in plasma of breast cancer patients.

Jurkovicova D, Smolkova B, Magyerkova M, Sestakova Z, Kajabova VH, Kulcsar L, Zmetakova I, Kalinkova L, Krivulcik T, Karaba M, Benca J, Sedlackova T, Minarik G, Cierna Z, Danihel L, Mego M, Chovanec M, Fridrichova I.

Oncotarget. 2017 Aug 24;8(44):77369-77384. doi: 10.18632/oncotarget.20484. eCollection 2017 Sep 29.

28.

The Chest Wall Tumor as a Rare Clinical Presentation of Hepatocellular Carcinoma Metastasis.

Porsok S, Mego M, Pinďák D, Duchoň R, Beniak J, Mardiak J.

Klin Onkol. Summer 2017;30(4):299-301. doi: 10.14735/amko2017299.

PMID:
28832177
29.

Circulating tumor cells and coagulation-Minireview.

Bystricky B, Reuben JM, Mego M.

Crit Rev Oncol Hematol. 2017 Jun;114:33-42. doi: 10.1016/j.critrevonc.2017.04.003. Epub 2017 Apr 6. Review.

PMID:
28477745
30.

Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.

Bystricky B, Cierna Z, Sieberova G, Janega P, Karaba M, Minarik G, Benca J, Sedlackova T, Jurisova S, Gronesova P, Pindak D, Macuch J, Mardiak J, Mego M.

Anticancer Res. 2017 May;37(5):2727-2734.

PMID:
28476852
31.

Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors.

Kalavska K, Cierna Z, Chovanec M, Takacova M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Machalekova K, Kajo K, Spanik S, Mardiak J, Babal P, Pastorekova S, Mego M.

Oncol Lett. 2017 Apr;13(4):2177-2185. doi: 10.3892/ol.2017.5745. Epub 2017 Feb 14.

32.

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Svetlovska D, Kalavska K, Rejlekova K, Spanik S, Kajo K, Babal P, Mardiak J, Mego M.

Oncotarget. 2017 Mar 28;8(13):21794-21805. doi: 10.18632/oncotarget.15585.

33.

Colonic gas homeostasis: Mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans.

Mego M, Accarino A, Tzortzis G, Vulevic J, Gibson G, Guarner F, Azpiroz F.

Neurogastroenterol Motil. 2017 Sep;29(9). doi: 10.1111/nmo.13080. Epub 2017 Apr 18.

PMID:
28418214
34.

Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.

Bystricky B, Jurisova S, Karaba M, Minarik G, Benca J, Sedlácková T, Tothova L, Vlkova B, Cierna Z, Janega P, Manasova D, Gronesova P, Pindak D, Mardiak J, Celec P, Mego M.

Anticancer Res. 2017 Apr;37(4):1787-1791.

PMID:
28373442
35.

Novel strategies for comprehensive mutation screening of the APC gene.

Wachsmannova L, Mego M, Stevurkova V, Zajac V, Ciernikova S.

Neoplasma. 2017;64(3):338-343. doi: 10.4149/neo_2017_303. Review.

PMID:
28253712
36.

Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients.

Svetlovska D, Miskovska V, Cholujova D, Gronesova P, Cingelova S, Chovanec M, Sycova-Mila Z, Obertova J, Palacka P, Rajec J, Kalavska K, Usakova V, Luha J, Ondrus D, Spanik S, Mardiak J, Mego M.

Clin Genitourin Cancer. 2017 Jun;15(3):411-416.e2. doi: 10.1016/j.clgc.2017.01.027. Epub 2017 Feb 8.

PMID:
28237180
37.

Differences in Incidence and Biological Characteristics of Breast Cancer between Roma and Non-Roma Patients in Slovakia.

Reckova M, Mardiak J, Plank L, Vulevova M, Cingelová S, Mego M.

Klin Onkol. Winter 2017;30(1):48-54. doi: 10.14735/amko201748.

PMID:
28185465
38.

Differences in Age-distribution, Oncological Diagnoses and Stage in Roma and Non-Roma Cancer Patients Registered at the Outpatient Oncology Department Poprad in 2014 and 2015 - a Retrospective Study.

Reckova M, Mardiak J, Beniak J, Kakalejcik M, Medvecova L, Cingelová S, Mego M.

Klin Onkol. Winter 2017;30(1):41-47. doi: 10.14735/amko201741.

PMID:
28185464
39.

Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study.

Mego M, Manichanh C, Accarino A, Campos D, Pozuelo M, Varela E, Vulevic J, Tzortzis G, Gibson G, Guarner F, Azpiroz F.

Aliment Pharmacol Ther. 2017 Mar;45(5):670-680. doi: 10.1111/apt.13931. Epub 2017 Jan 12.

40.

High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset.

Casal-Dominguez M, Pinal-Fernandez I, Mego M, Accarino A, Jubany L, Azpiroz F, Selva-O'callaghan A.

Muscle Nerve. 2017 Sep;56(3):386-392. doi: 10.1002/mus.25507. Epub 2017 Apr 4.

PMID:
27935079
41.

High-Grade Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation.

Mečiarová I, Sojáková M, Mego M, Mardiak J, Pohlodek K.

Int J Surg Pathol. 2016 Dec;24(8):738-742. Epub 2016 Jun 27.

PMID:
27353078
42.

The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.

Sestakova Z, Kalavska K, Hurbanova L, Jurkovicova D, Gursky J, Chovanec M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Cingelova S, Spanik S, Mardiak J, Chovanec M, Mego M.

Oncotarget. 2016 Nov 15;7(46):75996-76005. doi: 10.18632/oncotarget.12515.

43.

Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients.

Kalavska K, Chovanec M, Zatovicova M, Takacova M, Gronesova P, Svetlovska D, Baratova M, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Cierna Z, Kajo K, Spanik S, Babal P, Mardiak J, Pastorekova S, Mego M.

Oncol Lett. 2016 Oct;12(4):2590-2598. Epub 2016 Aug 16.

44.

Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function.

Azpiroz F, Molne L, Mendez S, Nieto A, Manichanh C, Mego M, Accarino A, Santos J, Sailer M, Theis S, Guarner F.

J Clin Gastroenterol. 2017 Aug;51(7):619-625. doi: 10.1097/MCG.0000000000000723.

45.

Internalization property of intestinal bacteria in colon cancer and HIV/AIDS patients.

Wachsmannova L, Ciernikova S, Majek J, Mego M, Stevurkova V, Zajac V.

Neuro Endocrinol Lett. 2016 Jul;37(3):245-250.

PMID:
27618600
46.

Colonic content: effect of diet, meals, and defecation.

Bendezú RA, Mego M, Monclus E, Merino X, Accarino A, Malagelada JR, Navazo I, Azpiroz F.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12930. Epub 2016 Aug 21.

PMID:
27545449
47.

Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ.

Cierna Z, Mego M, Jurisica I, Machalekova K, Chovanec M, Miskovska V, Svetlovska D, Kalavska K, Rejlekova K, Kajo K, Mardiak J, Babal P.

BMC Cancer. 2016 Aug 4;16:597. doi: 10.1186/s12885-016-2644-z.

48.

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.

Mego M, Gao H, Cohen EN, Anfossi S, Giordano A, Tin S, Fouad TM, De Giorgi U, Giuliano M, Woodward WA, Alvarez RH, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M, Reuben JM.

Oncotarget. 2017 May 30;8(22):35656-35668. doi: 10.18632/oncotarget.10290.

49.

Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.

Mego M, Gao H, Cohen EN, Anfossi S, Giordano A, Sanda T, Fouad TM, De Giorgi U, Giuliano M, Woodward WA, Alvarez RH, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M, Reuben JM.

J Cancer. 2016 Jun 3;7(9):1095-104. doi: 10.7150/jca.13098. eCollection 2016.

50.

Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood.

Smolkova B, Mego M, Horvathova Kajabova V, Cierna Z, Danihel L, Sedlackova T, Minarik G, Zmetakova I, Krivulcik T, Gronesova P, Karaba M, Benca J, Pindak D, Mardiak J, Reuben JM, Fridrichova I.

Transl Oncol. 2016 Jun;9(3):184-90. doi: 10.1016/j.tranon.2016.03.004. Epub 2016 Apr 25.

Supplemental Content

Support Center